Peter Attia· MD
from a prevention standpoint it's much easier to go after something that's necessary because you only have to block that versus once the disease has already taken hold you're advancing something that's multifactorial
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
from a prevention standpoint it's much easier to go after something that's necessary because you only have to block that versus once the disease has already taken hold you're advancing something that's multifactorial
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
there's no real need for apob you know we could we could survive with no circulating apob and we wouldn't have any atherosclerotic disease so every time you get a little depressed and have that thought you can also realize how fortunate are we that the biology of apob is so much more well understood than that of apo a now i'm talking apo big a and that eradicating apob is becoming easier and easier and easier and safer and safer and safer